Akso Health Group
AHG
$1.620 -2.99%
Exchange: NASDAQ | Sector: Financial Services | Industry: Financial Credit Services
Q2 2024
Published: Jan 3, 2024

Earnings Highlights

  • Revenue of $0.45M down 92.5% year-over-year
  • EPS of $-0.20 decreased by 302.6% from previous year
  • Gross margin of 4.3%
  • Net income of -1.53M
  • "N/A" - N/A

Akso Health Group (AHG) QQ2 2024 Results: Revenue Contraction, Persistent Losses, and Liquid Balance Sheet Amid Platform Transitions

Executive Summary

AHG reported QQ2 2024 results showing a sharp year-over-year and quarter-over-quarter revenue decline, accompanied by negative profitability metrics. Revenue of 446,792 (USD) declined 92.5% YoY and 41.2% QoQ, yielding a gross profit of 19,415 and a gross margin of 4.35%. Operating income Turned negative at -1,157,924 and net income was -1,532,088 with an EPS of -0.20. The company carries a clearly negative earnings trajectory despite a solid liquidity position: cash and cash equivalents of 9,211,639 and a net cash position of -8,861,639 (net debt), underpinning financial flexibility. On the balance sheet, AHG exhibits a healthy current ratio of 1.46 and a cash ratio of 0.798, with total assets of 16,880,618 and total liabilities of 11,549,145. Operating cash flow was modest at 121,168, while net cash provided by operating activities helped fund investing and financing activities, and FX effects contributed positively to cash. These dynamics suggest the quarter was characterized by structural revenue normalization challenges and ongoing profitability pressures, even as liquidity supports potential strategic pivots and working-capital optimization.

Key Performance Indicators

Revenue

446.79K
QoQ: -41.24% | YoY:-92.46%

Gross Profit

19.42K
4.35% margin
QoQ: -53.39% | YoY:-96.55%

Operating Income

-1.16M
QoQ: 63.37% | YoY:-951.89%

Net Income

-1.53M
QoQ: 48.89% | YoY:-287.90%

EPS

-0.20
QoQ: -42.86% | YoY:-302.63%

Revenue Trend

Margin Analysis

Key Insights

Revenue: 446,792; YoY change: -92.46%; QoQ change: -41.24% Gross Profit: 19,415; Gross Margin: 4.35% Operating Income: -1,157,924; Operating Margin: -2.59% Net Income: -1,532,088; Net Margin: -3.43% EPS: -0.20; EPS Diluted: -0.20 Balance Sheet Signals: Cash and cash equivalents 9,211,639; Total Assets 16,880,618; Total Current Assets 16,880,618; Total Current Liabilities 11,549,145; Current Ratio 1.46; Quick Ratio 1.36; Cash Ratio 0.80; Net Debt / Cash Position: net debt -8,861,639 Cash Flow: Ne...

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2024 0.76 -0.13 +14.8% View
Q3 2024 0.76 -0.13 +14.8% View
Q2 2024 0.45 -0.20 -92.5% View
Q1 2024 0.45 -0.20 -92.5% View
Q4 2023 0.66 -0.96 -92.5% View